PEAK6 Investments’s OptimizeRx OPRX Stock Holding History

PEAK6 Investments’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5,925	Closed	-$56.9K	–	4672
2023 Q3	$46.1K	Buy	+5,925	New	+$64.5K	﹤0.01%	3647
2023 Q2	–	Sell	-38,571	Closed	-$549K	–	4478
2023 Q1	$564K	Buy	38,571 +36,249	+1,561%	+$607K	﹤0.01%	2293
2022 Q4	$39K	Sell	2,322 -13,001	-85%	-$225K	﹤0.01%	3913
2022 Q3	$227K	Buy	+15,323	New	+$303K	﹤0.01%	3563
2022 Q2	–	Sell	-89,315	Closed	-$2.65M	–	4946
2022 Q1	$3.37M	Buy	89,315 +47,639	+114%	+$2.11M	0.01%	1394
2021 Q4	$2.59M	Buy	+41,676	New	+$3.16M	0.01%	1648
2021 Q2	–	Sell	-5,079	Closed	-$258K	–	5581
2021 Q1	$248K	Buy	+5,079	New	+$245K	﹤0.01%	3775
2020 Q3	–	Sell	-7,774	Closed	-$101K	–	4736
2020 Q2	$101K	Buy	+7,774	New	+$84.5K	﹤0.01%	3795
2019 Q4	–	Sell	-17,990	Closed	-$260K	–	3864
2019 Q3	$260K	Buy	+17,990	New	+$278K	﹤0.01%	2735

Other funds holding OPRX

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Samjo Management New York $293M AUM 57.03% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $549M AUM 179.59% 1-Year Est. Return

PEAK6 Investments's OPRX Position: Q4 2023 in Review

PEAK6 Investments sold out of OptimizeRx (OPRX) in Q4 2023, closing a stake of 5,925 shares — an estimated $56.9K sold.

PEAK6 Investments first reported a position in OPRX in Q3 2019 and held it in 9 quarters. The position peaked at $3.37M in Q1 2022. 98 funds tracked by Wall St. Rank hold OPRX as of Q4 2023.

PEAK6 Investments reported no remaining OptimizeRx position as of Q4 2023 after selling out during the quarter.
PEAK6 Investments sold 5,925 OptimizeRx shares in Q4 2023, an estimated $56.9K.
PEAK6 Investments first reported a position in OptimizeRx in Q3 2019 and held it in 9 quarters.
PEAK6 Investments's OptimizeRx position peaked at $3.37M in Q1 2022.
98 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2023.

Based on PEAK6 Investments's 13F filing for Q4 2023, filed 13 Feb 2024.